Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers.

Larsen A, Hovdenak N, Karlsdottir A, Wentzel-Larsen T, Dahl O, Fagerhol MK.

Scand J Gastroenterol. 2004 Nov;39(11):1113-8.

PMID:
15545170
[PubMed - indexed for MEDLINE]
2.

A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment.

Hille A, Schmidt-Giese E, Hermann RM, Herrmann MK, Rave-Fränk M, Schirmer M, Christiansen H, Hess CF, Ramadori G.

Scand J Gastroenterol. 2008 Jan;43(1):52-8.

PMID:
18938774
[PubMed - indexed for MEDLINE]
3.

Faecal calprotectin and lactoferrin values during irradiation of prostate cancer correlate with chronic radiation proctitis: results of a prospective study.

Hille A, Rave-Fränk M, Christiansen H, Herrmann MK, Kertesz T, Hermann RM, Wolff HA, Schirmer M, Hess CF, Ramadori G.

Scand J Gastroenterol. 2009;44(8):939-46. doi: 10.1080/00365520903039952.

PMID:
19504404
[PubMed - indexed for MEDLINE]
4.

Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.

Larsen A, Bjørge B, Klementsen B, Helgeland L, Wentzel-Larsen T, Fagerhol MK, Hovdenak N, Dahl O.

Acta Oncol. 2007;46(5):639-50.

PMID:
17562440
[PubMed - indexed for MEDLINE]
5.

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease.

Sipponen T, Savilahti E, Kärkkäinen P, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.

Inflamm Bowel Dis. 2008 Oct;14(10):1392-8. doi: 10.1002/ibd.20490.

PMID:
18484671
[PubMed - indexed for MEDLINE]
6.

Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.

Joshi S, Lewis SJ, Creanor S, Ayling RM.

Ann Clin Biochem. 2010 May;47(Pt 3):259-63. doi: 10.1258/acb.2009.009061. Epub 2009 Sep 9.

PMID:
19740914
[PubMed - indexed for MEDLINE]
7.

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn's disease and histological findings.

Sipponen T, Kärkkäinen P, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M.

Aliment Pharmacol Ther. 2008 Nov 15;28(10):1221-9. doi: 10.1111/j.1365-2036.2008.03835.x. Epub 2008 Aug 26.

PMID:
18752630
[PubMed - indexed for MEDLINE]
8.

Faecal DNA and calprotectin as biomarkers of acute intestinal toxicity in patients undergoing pelvic radiotherapy.

Varela E, Antolín M, Guarner F, Verges R, Giralt J, Malagelada JR.

Aliment Pharmacol Ther. 2009 Jul 1;30(2):175-85. doi: 10.1111/j.1365-2036.2009.04019.x. Epub 2009 Apr 15.

PMID:
19392859
[PubMed - indexed for MEDLINE]
9.

Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.

Schröder O, Naumann M, Shastri Y, Povse N, Stein J.

Aliment Pharmacol Ther. 2007 Oct 1;26(7):1035-42.

PMID:
17877510
[PubMed - indexed for MEDLINE]
Free Article
10.

Fecal tumor necrosis factor-alpha and calprotectin as differential diagnostic markers for severe diarrhea of small infants.

Kapel N, Roman C, Caldari D, Sieprath F, Canioni D, Khalfoun Y, Goulet O, Ruemmele FM.

J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):396-400.

PMID:
16205505
[PubMed - indexed for MEDLINE]
11.

Metabolic and inflammatory faecal markers in collagenous colitis.

Wildt S, Nordgaard-Lassen I, Bendtsen F, Rumessen JJ.

Eur J Gastroenterol Hepatol. 2007 Jul;19(7):567-74.

PMID:
17556903
[PubMed - indexed for MEDLINE]
12.

Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.

Montalto M, Curigliano V, Santoro L, Lombardi M, Covino M, Cammarota G, Dalvai S, D'Onofrio F, Gasbarrini A, Gasbarrini G.

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):965-7.

PMID:
16894309
[PubMed - indexed for MEDLINE]
13.

Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.

Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL.

Scand J Gastroenterol. 2010 Mar;45(3):325-31. doi: 10.3109/00365520903483650.

PMID:
20034360
[PubMed - indexed for MEDLINE]
14.

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome.

Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ.

Clin Chem Lab Med. 2008;46(9):1275-80. doi: 10.1515/CCLM.2008.246. Erratum in: Clin Chem Lab Med. 2008;46(12):1798.

PMID:
18597588
[PubMed - indexed for MEDLINE]
15.

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.

D'Incà R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC.

Int J Colorectal Dis. 2007 Apr;22(4):429-37. Epub 2006 Jul 13.

PMID:
16838143
[PubMed - indexed for MEDLINE]
16.

[Utility of fecal markers of inflammation in the diagnostics of inflammatory bowel diseases].

Borkowska A, Liberek A, Plata-Nazar K, Kamińiska B.

Med Wieku Rozwoj. 2010 Jan-Mar;14(1):37-41. Review. Polish.

PMID:
20608427
[PubMed - indexed for MEDLINE]
17.

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease.

Lamb CA, Mohiuddin MK, Gicquel J, Neely D, Bergin FG, Hanson JM, Mansfield JC.

Br J Surg. 2009 Jun;96(6):663-74. doi: 10.1002/bjs.6593.

PMID:
19384912
[PubMed - indexed for MEDLINE]
18.

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.

Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.

Dig Liver Dis. 2008 Jul;40(7):547-53. doi: 10.1016/j.dld.2008.01.017. Epub 2008 Mar 20.

PMID:
18358796
[PubMed - indexed for MEDLINE]
19.

Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.

Sugi K, Saitoh O, Hirata I, Katsu K.

Am J Gastroenterol. 1996 May;91(5):927-34.

PMID:
8633583
[PubMed - indexed for MEDLINE]
20.

Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.

Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR.

Eur J Gastroenterol Hepatol. 2008 Mar;20(3):174-9. doi: 10.1097/MEG.0b013e3282f1c9a7.

PMID:
18301296
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk